SI9300581A - Transdermal therapeutic system with estradiol as activ substance - Google Patents

Transdermal therapeutic system with estradiol as activ substance Download PDF

Info

Publication number
SI9300581A
SI9300581A SI9300581A SI9300581A SI9300581A SI 9300581 A SI9300581 A SI 9300581A SI 9300581 A SI9300581 A SI 9300581A SI 9300581 A SI9300581 A SI 9300581A SI 9300581 A SI9300581 A SI 9300581A
Authority
SI
Slovenia
Prior art keywords
estradiol
humidity
transdermal therapeutic
therapeutic system
active substance
Prior art date
Application number
SI9300581A
Other languages
English (en)
Slovenian (sl)
Inventor
Michael Horstmann
Sylvia Hahn
Reinhold Meconi
Robert-Peter Klein
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6472230&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI9300581(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of SI9300581A publication Critical patent/SI9300581A/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
SI9300581A 1992-11-06 1993-11-05 Transdermal therapeutic system with estradiol as activ substance SI9300581A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4237453A DE4237453C1 (fi) 1992-11-06 1992-11-06

Publications (1)

Publication Number Publication Date
SI9300581A true SI9300581A (en) 1994-06-30

Family

ID=6472230

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9300581A SI9300581A (en) 1992-11-06 1993-11-05 Transdermal therapeutic system with estradiol as activ substance

Country Status (24)

Country Link
US (1) US5912008A (fi)
EP (1) EP0716599B1 (fi)
JP (1) JP3237016B2 (fi)
KR (1) KR100306946B1 (fi)
AT (1) ATE164516T1 (fi)
AU (1) AU678408B2 (fi)
CA (1) CA2147172C (fi)
CZ (1) CZ286907B6 (fi)
DE (2) DE4237453C1 (fi)
DK (1) DK0716599T3 (fi)
ES (1) ES2117152T3 (fi)
FI (1) FI113339B (fi)
HR (1) HRP931360B1 (fi)
HU (1) HU221847B1 (fi)
IL (1) IL107395A (fi)
MY (1) MY118171A (fi)
NO (1) NO311783B1 (fi)
NZ (1) NZ257137A (fi)
PL (1) PL174604B1 (fi)
SI (1) SI9300581A (fi)
SK (1) SK279911B6 (fi)
WO (1) WO1994010984A1 (fi)
YU (1) YU69693A (fi)
ZA (1) ZA938257B (fi)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU633887B2 (en) * 1989-02-28 1993-02-11 Teijin Limited Poultice and preparation thereof
CA2161004C (en) * 1993-04-20 2004-10-26 Wilfried Fischer Active ingredient patch
DE4429664C2 (de) * 1994-08-20 1997-09-11 Lohmann Therapie Syst Lts Estradiol-TTS mit wasserbindenden Zusätzen und Verfahren zu seiner Herstellung
US5906830A (en) * 1995-09-08 1999-05-25 Cygnus, Inc. Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
DE19600347A1 (de) * 1996-01-08 1997-07-10 Lohmann Therapie Syst Lts Hauthaftende pharmazeutische Zubereitung, insbesondere TTS zur Abgabe von 17-beta-Estradiol an den menschlichen Organismus
DE19701949A1 (de) * 1997-01-13 1998-07-16 Jenapharm Gmbh Transdermales therapeutisches System
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
DE19827732A1 (de) * 1998-06-22 1999-12-23 Rottapharm Bv Transdermales System vom Matrix-Typ zur Abgabe von Wirkstoffen mit einer hohen Abgaberate von Steroid-Hormonen und die Verwendung eines derartigen Systems zur Hormonersatztherapie
JP4399044B2 (ja) * 1998-10-14 2010-01-13 久光製薬株式会社 吸収促進剤及び該吸収促進剤を有してなる経皮吸収製剤
US6631186B1 (en) * 1999-04-09 2003-10-07 Sbc Technology Resources, Inc. System and method for implementing and accessing call forwarding services
DE19925613A1 (de) 1999-06-04 2000-12-07 Lohmann Therapie Syst Lts Verbundlaminat und Verfahren zu seiner Herstellung
ITRM20060440A1 (it) * 2006-08-10 2008-02-11 Carmine Antropoli Uso della nifedipina per il trattamento antirughe
US20100087768A1 (en) * 2008-10-02 2010-04-08 Forlano Paula Transdermal drug delivery system for liquid active ingredient
DE102010026903A1 (de) 2010-07-12 2012-01-12 Amw Gmbh Transdermales therapeutisches System mit Avocadoöl oder Palmöl als Hilfsstoff
WO2013006613A1 (en) 2011-07-05 2013-01-10 Novan, Inc. Methods of manufacturing topical compositions and apparatus for same
EP2729131B1 (en) * 2011-07-05 2020-04-15 Novan, Inc. Topical compositions
DE102012000369A1 (de) 2012-01-11 2013-07-11 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Transdermales therapeutisches System mit Cholinesterase-Hemmer
US9855211B2 (en) 2013-02-28 2018-01-02 Novan, Inc. Topical compositions and methods of using the same
US10322082B2 (en) 2014-07-11 2019-06-18 Novan, Inc. Topical antiviral compositions and methods of using the same
BR112017000456B1 (pt) 2014-07-11 2022-12-13 Novan, Inc Uso de um ingrediente farmacêutico ativo de liberação de óxido nítrico e composição tópica para tratamento e/ou prevenção de uma infecção viral
CN116585257A (zh) 2016-04-13 2023-08-15 诺万公司 用于治疗感染的组合物、系统、试剂盒和方法
DE102017127433A1 (de) 2017-11-21 2019-05-23 Lts Lohmann Therapie-Systeme Ag TTS auf Basis von klebenden Weichmacher-Polymer-Matrices

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR527450A (fr) * 1919-12-04 1921-10-25 Gilbert Mahaut Système et dispositif pour la combustion des huiles lourdes dans les foyers industriels et autres
US4435180A (en) * 1982-05-25 1984-03-06 Alza Corporation Elastomeric active agent delivery system and method of use
GB2138286B (en) * 1983-04-19 1986-10-08 Dr Christopher Harry Mortimer Pharmaceutical composition for the treatment of hair loss
EP0186019B1 (de) * 1984-12-22 1993-10-06 Schwarz Pharma Ag Wirkstoffpflaster
US5145682A (en) * 1986-05-30 1992-09-08 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for postmenopausal syndrome treatment and process for administration
US5023084A (en) * 1986-12-29 1991-06-11 Rutgers, The State University Of New Jersey Transdermal estrogen/progestin dosage unit, system and process
FR2612785A1 (fr) * 1987-03-25 1988-09-30 Lhd Lab Hygiene Dietetique Dispositif auto-adhesif d'administration d'un principe actif par voie percutanee
US4863738A (en) * 1987-11-23 1989-09-05 Alza Corporation Skin permeation enhancer compositions using glycerol monooleate
US4994267A (en) * 1988-03-04 1991-02-19 Noven Pharmaceuticals, Inc. Transdermal acrylic multipolymer drug delivery system
AU633887B2 (en) * 1989-02-28 1993-02-11 Teijin Limited Poultice and preparation thereof
DE3933460A1 (de) * 1989-10-06 1991-04-18 Lohmann Therapie Syst Lts Oestrogenhaltiges wirkstoffpflaster
WO1991005529A1 (en) * 1989-10-13 1991-05-02 Watson Laboratories, Inc. Drug delivery systems and matrix therefor
AR246186A1 (es) * 1989-11-17 1994-07-29 Beta Pharm Co Procedimiento para fabricar un dispositivo para administrar estradiol por via transdermica.
DE4002281A1 (de) * 1990-01-26 1991-08-01 Lohmann Therapie Syst Lts Transdermales therapeutisches system mit dem wirkstoff tulobuterol
WO1991017752A1 (fr) * 1990-05-17 1991-11-28 Hisamitsu Pharmaceutical Co., Inc. Preparation a administration percutanee, contenant de l'×stradiol

Also Published As

Publication number Publication date
DK0716599T3 (da) 1999-01-11
DE59308360D1 (de) 1998-05-07
NO951765L (no) 1995-05-05
FI952115A0 (fi) 1995-05-03
WO1994010984A1 (de) 1994-05-26
CZ116295A3 (en) 1995-12-13
EP0716599A1 (de) 1996-06-19
HU221847B1 (hu) 2003-02-28
SK279911B6 (sk) 1999-05-07
YU69693A (sh) 1997-07-31
NZ257137A (en) 1996-09-25
EP0716599B1 (de) 1998-04-01
SK58095A3 (en) 1995-11-08
AU678408B2 (en) 1997-05-29
CA2147172C (en) 2003-12-23
AU5338694A (en) 1994-06-08
KR950703940A (ko) 1995-11-17
MY118171A (en) 2004-09-30
PL308532A1 (en) 1995-08-21
JPH08502987A (ja) 1996-04-02
CZ286907B6 (en) 2000-08-16
IL107395A0 (en) 1994-01-25
HRP931360A2 (en) 1995-02-28
HU9501318D0 (en) 1995-06-28
KR100306946B1 (ko) 2002-04-24
DE4237453C1 (fi) 1993-08-19
ATE164516T1 (de) 1998-04-15
US5912008A (en) 1999-06-15
ES2117152T3 (es) 1998-08-01
FI952115A (fi) 1995-05-03
ZA938257B (en) 1994-06-08
HUT71681A (en) 1996-01-29
JP3237016B2 (ja) 2001-12-10
IL107395A (en) 1997-08-14
CA2147172A1 (en) 1994-05-26
NO951765D0 (no) 1995-05-05
FI113339B (fi) 2004-04-15
NO311783B1 (no) 2002-01-28
HRP931360B1 (en) 1999-12-31
PL174604B1 (pl) 1998-08-31

Similar Documents

Publication Publication Date Title
SI9300581A (en) Transdermal therapeutic system with estradiol as activ substance
US5352456A (en) Device for administering drug transdermally which provides an initial pulse of drug
AU649732B2 (en) Transdermal device
KR101171814B1 (ko) 펜타닐 함유 점착성 제제
EP2524692A1 (en) Anti-inflammatory analgesic adhesive patch for external use
PT697860E (pt) Sistema teraputico transdermico que contem estradiol
SI9300387A (en) Transdermale therapeutic system containing active 17-beta estradiol (dry acid)
KR100473677B1 (ko) 물리적 특성이 향상된 폴리아크릴레이트 매트릭스를 구비한 경피 또는 국소 플래스터 시스템
US20090220580A1 (en) Percutaneous Absorption Formulation
CZ289313B6 (cs) Transdermální terapeutický systém ve formě náplasti
US5989585A (en) Transdermal therapeutic system (TTS) containing vitamin E for the treatment of drug dependency
PL201222B1 (pl) Preparat transdermalny lazoksyfenu, urządzenie do podawania lazoksyfenu, oraz zastosowanie lazoksyfenu
US6733785B1 (en) Moisture-sensitive preparation of percutaneous absorption type
PL180965B1 (pl) Transdermalny system terapeutyczny zawierający estradiol
US5827245A (en) Transdermal therapeutic system comprising the active subtance 17-β-Estradiol (Anhydrous)
SI9300589A (en) Transdermal therapeutic system for administration of fisostigmin and procedure for its preparation
JP3242324B2 (ja) ニトログリセリン経皮吸収型製剤
HUT77093A (hu) Ösztradiol-transzdermális terápiás rendszer vízmegkötő adalékkal és eljárás előállítására
WO1993000057A1 (en) Transdermal nicotine absorption dosage unit and process